About The Report
Digital Therapeutics Market Size and Share Forecast Outlook 2025 to 2035
The digital therapeutics market is valued at USD 9.2 billion in 2025 and is expected to reach USD 82.0 billion by 2035 at a CAGR of 24.4%. Monotherapy holds 57.8% share in 2025 as demand strengthens for clinically validated software solutions that support standalone behavioral and chronic disease interventions without reliance on traditional pharmaceuticals. Prevention applications lead with a 42.6% share as health systems, insurers, and employers prioritize early risk identification and digital behavioral programs to reduce long term disease burden and treatment costs.
Growth is driven by rising incidence of chronic conditions, rising acceptance of remote health platforms, and growing patient preference for accessible digital tools. The surge in mobile engagement, real time monitoring, and AI empowered health coaching is strengthening adoption across diabetes management, CNS disorders, cardiovascular disease, and obesity care. Despite challenges related to reimbursement pathways, data validation, and stakeholder engagement, major players continue to expand regulated digital therapy portfolios, supported by stronger clinical evidence and cross industry collaborations.
Quick Stats for Digital Therapeutics Market
- Digital Therapeutics Market Industry Value (2025): USD 9.2 billion
- Digital Therapeutics Market Forecast Value (2035): USD 82.0 billion
- Digital Therapeutics Market Forecast CAGR: 24.4%
- Leading Segment in Digital Therapeutics Market in 2025: Monotherapy (57.8%)
- Key Growth Region in Digital Therapeutics Market: North America, Asia-Pacific, Europe
- Top Key Players in Digital Therapeutics Market: Teladoc Health, Inc., Click Therapeutics, Inc., Welldoc, HYGIEIA, DarioHealth Corp, BigHealth, Orexo AB, Akili Interactive Labs, Inc., Freespira, Voluntis, Kaia Health, Kaiku Health, Theranica Bio-Electronics Ltd., Propeller Health, Orexo US, Inc., TALi Digital Limited, Limbix Health, Inc.
| Metric | Value |
|---|---|
| Digital Therapeutics Market Estimated Value in (2025 E) | USD 9.2 billion |
| Digital Therapeutics Market Forecast Value in (2035 F) | USD 82.0 billion |
| Forecast CAGR (2025 to 2035) | 24.4% |
Rationale for Segmental Growth in the Digital Therapeutics Market
Insights into the Monotherapy Segment
The monotherapy segment, accounting for 57.8% share in 2025, leads the market as demand rises for digital interventions that deliver clinically measurable outcomes without combination with drug based treatments. These solutions are designed to modify patient behaviors, improve adherence, and generate personalized therapy plans through structured software models. Health systems favor monotherapy platforms because they reduce treatment costs and support scalable behavioral programs across chronic disease categories. Regulatory recognition of software as a medical therapy, increasing prescription based digital solutions, and growing physician acceptance continue to reinforce the segment. As clinical trials validate therapeutic efficacy across conditions such as ADHD, insomnia, diabetes, and anxiety, monotherapy is set to maintain strong momentum through the forecast period.
Insights into the Prevention Application Segment
The prevention segment secures a 42.6% share in 2025 due to rising emphasis on early risk mitigation for chronic diseases. Digital therapeutics provide structured behavioral training, monitoring tools, and lifestyle management programs that delay disease onset and reduce medical complications. Employers, insurers, and population health programs increasingly integrate prevention focused platforms to reduce long term healthcare spending. Users prefer prevention oriented digital therapies for their simple onboarding, continuous feedback loops, and ability to track real time improvements. As demand increases for digital coaching, predictive analytics, and personalized prevention pathways, the segment continues to attract strong investment and broader patient adoption across global markets.
2020 to 2024 Digital Therapeutics Market Historic Outlook Vs Forecast for 2025 to 2035
The digital therapeutics market grew at a CAGR of 22.0% between 209.27 and 2035.2. The market value for global digital therapeutics held nearly 2.7% of the overall USD 9.246 Billion digital health market in 2035.2.
The power of mobile technology to capture and hold people's attention is well known. A rising number of start-ups and established technology players are betting on that power to help people enhance their health outcomes in measurable ways.
These companies are driving software and health-care convergence in ways that can potentially change how the conventional approach of the life sciences industry, which involves both large pharma companies and medical technology or medical device companies, supports the patient health-care journey from beginning to end, spawning a new branch of medicine known as digital therapeutics.
Conventional therapies and treatments are still unable to meet unmet patient demand, while digital medicines offer the potential to do so. Enterprises that use digital therapies to close these gaps, together with substantially shorter product development timetables, may have a considerable edge over traditional life sciences companies.
Rising prevalence of preventable chronic diseases, the pressing need to regulate the cost of health care, a need for safe and accessible workarounds for the treatment of chronic and mental health diseases, a growing focus on predictive, preventative, personalised, and participatory healthcare, increasing investments in digital therapeutics are driving growth in the digital therapeutics market.
Digital therapeutics provide patient-oriented solutions through aspects such as digital behavioural interventions to devise evidence-based solutions on patient data, artificial intelligence and machine learning interventions, mobile health applications, gamification, and virtual reality. Driven by this, the market is expected to grow at a 24.4% CAGR and offer an absolute $ opportunity of nearly USD 9.2 Billion between 2025 and 2025.
What are the Key Opportunities Propelling the Demand for Digital Therapeutics?
Numerous start-ups and existing technology companies are banking on the ability of mobile technology to help people improve their health in quantifiable ways. Manufacturers are driving software and healthcare convergence in ways that are expected to change the life sciences industry's traditional approach, which includes both large pharma and medical technology or medical device companies, supports the patient's medical journey. This has spawned a new branch of medicine known as digital therapeutics and will provide lucrative opportunities for growth over the forecast period.
Furthermore, digital therapeutics provide pharmaceutical and MedTech businesses with a low-cost approach to differentiate products, especially when compared to the research and development costs generally involved with traditional medicine or medical device.
Many businesses are refocusing their R&D efforts away from core product lines and toward revolutionary innovation. Digital medicines also have the potential to lengthen product life cycles, differentiate in-development goods, and cover market gaps that traditional medicine may not be able to fill. All these factors are expected to augment the growth in the market over the assessment period.
What Factors are Limiting Sales in the Digital Therapeutics Market?
Wearable healthcare faces several challenges, including the fact that the data provided cannot always be used to track, diagnose, and treat health disorders due to ongoing concerns about data accuracy, consistency, and privacy.
Additionally, stakeholder awareness, acceptance, and engagement are issues for many firms that have joined the DTx industry. Most DTx solutions have entered the market with product-centric revenue models and go-to-market strategies to date.
Instead of satisfying unmet requirements of patients and other essential stakeholders across the end-to-end continuum of care, their focus has been on selling more products. As a result, the market for isolated digital point solutions is fragmented, confused, and overcrowded. There is no genuinely comprehensive, patient-centric experience to assist patients in navigating the present complex healthcare system.
As a result of the additional time and money spent on product development, the marketing and commercial sales teams are underp ressure to produce successful go-to-market plans for DTx launch, scale-up, and growth. These factors, together, induce a restrictive impact upon the growth of the overall digital therapeutics market.
Country-wise Insights
What Makes the USA the Largest Market for Digital Therapeutics?
Rapid Adoption of Connective Technology-Based Medical Equipment Will Fuel Sales of Digital Therapeutics
The USA dominated the North America digital therapeutics market in 2024, holding about 90.3% of the market share. As per FMI, the trend is projected to continue over the forecast period. Growth is associated with the high burden of chronic disease in the general population within the country.
Increasing incidence of gastrointestinal and central nervous system diseases is underpinning the demand for digital therapeutics. With growing adoption of telemedicine, integration and adoption of mobile health analytics in the USA, sales are expected to increase over the forecast period.
Why is China Considered a Lucrative Market for Digital Therapeutics?
Growing Demand for Digital Therapeutics for Insomnia Will Augment Growth
China is expected to account for 48.0% of the East Asia digital therapeutics market share in 2025. After the third wave of automation and digital technology integration propelled by the advent of the COVID-19 pandemic, China has established full automation solutions for medical and production facilities.
The local government has joined forces with leading DTx organisations with a joint commitment of 20 billion RMB ($32 billion) in funding support to formalise a massive DTx Industrial Park project, which is a promising indicator of Chinese DTx market progress. The project's details and funding proposal have yet to be revealed, but a newly built DTx Industrial Park in Zhejiang Province will soon serve as the DTx industrial flagship in China.
What is Driving the Germany Digital Therapeutics Market?
Rising Awareness Regarding Digital Therapeutics Technology Will Boost Sales in Germany
With a high volume of the disease burden associated with chronic ailments such as cardiovascular diseases, diabetes, and cancer, demand for digital therapeutics in Germany is anticipated to remain high. As per the report, the Germany digital therapeutics market will expand at a 20.6% CAGR over the forecast period.
In 2020, the German Parliament passed the Digital Healthcare Act (DigitaleVersorgung-Gesetz, or DVG), allowing all German doctors to prescribe digital treatments to publicly-insured patients in Germany. This has enhanced the accessibility of safe digital solutions for the treatment of chronic and mental health diseases.
Category-wise Insights
Which Digital Therapeutics Solution is Widely Adopted?
Demand for Combination Therapy Will Gain Traction
Based on solution, the combination therapy segment is projected to account for 68.4% of the total market share in 2025. Combination therapy with biopharmaceuticals, or “smart drugs” offers an exciting way to improve patient adherence and outcomes. Pharmaceutical companies can assist patients in improving their health outcomes by digitising drugs and utilising digital interventions to encourage their proper usage.
Which Applications of Digital Therapeutics are Driving the Market?
Adoption of Digital Therapeutics for Disease Prevention Will Rise
In terms of applications, the prevention segment is forecast to hold 35.8% of the total market share in 2025. For patients at risk of developing more serious ailments, digital therapeutics are routinely used as a prophylactic measure. These prevention measures provide approaches and solutions that could delay the onset of the chronic disease.
Which Indication is More in Focus in the Digital Therapeutics Market?
Sales of Digital Therapeutics for Central Nervous Systems Disorders Will Boost Demand
By indication, sales in the central nervous system disorders segment will increase at a CAGR of 29.2% over the assessment period. Several drugs that are now in use were discovered as a result of drug discovery research intended to treat central nervous system (CNS) illnesses.
However, not all drugs can relieve patients of the symptoms of their disorders, and CNS dysfunction is still a medical area with many unmet needs. Medical solutions which utilize digital technologies can address these unmet needs.
Which Business Model is Most Preferred For Digital Therapeutics?
Sales of Digital Therapeutics Direct to Patients Will Gain Momentum
Based on distribution channel, the direct-to-patients/consumers segment will hold about 60.1% of the total market share over the forecast period. With the products being sold directly to the consumer, the availability of mobile health solutions provide customers with solutions linked to enhanced patient compliance and better clinical outcomes.
Competitive Landscape
The market for digital therapeutics is a fragmented. With the emergence of start-ups and other market players, the global market is likely to witness the heavy competition. Companies are aiming to launch digital health campaigns and software solutions for a comprehensive patient care regimen. For instance:
- Teladoc Health in February 2025 launched the “Chronic Care Complete” management solution aimed at improving health outcomes for patients living with chronic conditions.
- • In September 2024, Boehringer Ingelheim and Click Therapeutics agreed to collaborate on the development and commercialization of CT-155, a novel prescription digital therapy for schizophrenia.
Report Scope as per Digital Therapeutics Industry Analysis
| Attribute | Details |
|---|---|
| Forecast Period | 2025 to 2035 |
| Historical Data Available for | 2020 to 2024 |
| Market Analysis | USD Billion for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | The USA., Canada, Brazil, Mexico, Argentina, Germany, Italy, France, Spain, the UK., Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC Countries and Turkey |
| Key Companies Covered | Teladoc Health ;Inc.; Click Therapeutics, Inc.; Welldoc; HYGIEIA; DarioHealth Corp; BigHealth; Orexo AB; Akili Interactive Labs, Inc.; Freespira; Voluntis; Kaia Health; Kaiku Health; Theranica Bio-Electronics Ltd.; Propeller Health; Orexo US, Inc.; TALi Digital Limited; Limbix Health, Inc. |
| Key Market Segments Covered | Solution, Application, Indication, Business Model and Region |
Key Market Segments Covered in Digital Therapeutics Industry Research
By Solution:
- Monotherapy
- Combination Therapy
By Application:
- Prevention
- Management
- Treatment
By Indication:
- Diabetes
- Obesity
- Gastrointestinal Disorders
- Cardiovascular Disease
- Central Nervous Systems
- Others
By Business Model:
- Direct to consumer
- Fee-for-service
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa (MEA)
Frequently Asked Questions
How big is the digital therapeutics market in 2025?
The global digital therapeutics market is estimated to be valued at USD 9.2 billion in 2025.
What will be the size of digital therapeutics market in 2035?
The market size for the digital therapeutics market is projected to reach USD 82.0 billion by 2035.
How much will be the digital therapeutics market growth between 2025 and 2035?
The digital therapeutics market is expected to grow at a 24.4% CAGR between 2025 and 2035.
What are the key product types in the digital therapeutics market?
The key product types in digital therapeutics market are monotherapy and combination therapy.
Which application segment to contribute significant share in the digital therapeutics market in 2025?
In terms of application, prevention segment to command 42.6% share in the digital therapeutics market in 2025.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
- Historical Market Size Value (USD Million) Analysis, 2020 to 2024
- Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
- Y-o-Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Solution
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Solution , 2020 to 2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Solution , 2025 to 2035
- Monotherapy
- Combination Therapy
- Y-o-Y Growth Trend Analysis By Solution , 2020 to 2024
- Absolute $ Opportunity Analysis By Solution , 2025 to 2035
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Application
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Application, 2020 to 2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2025 to 2035
- Prevention
- Management
- Treatment
- Y-o-Y Growth Trend Analysis By Application, 2020 to 2024
- Absolute $ Opportunity Analysis By Application, 2025 to 2035
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Indication
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Indication, 2020 to 2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Indication, 2025 to 2035
- Diabetes
- Obesity
- Gastrointestinal Disorders
- Cardiovascular Disease
- Central Nervous Systems
- Others
- Y-o-Y Growth Trend Analysis By Indication, 2020 to 2024
- Absolute $ Opportunity Analysis By Indication, 2025 to 2035
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Business Model
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Business Model, 2020 to 2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Business Model, 2025 to 2035
- Direct to consumer
- Fee-for-service
- Y-o-Y Growth Trend Analysis By Business Model, 2020 to 2024
- Absolute $ Opportunity Analysis By Business Model, 2025 to 2035
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- USA
- Canada
- Mexico
- By Solution
- By Application
- By Indication
- By Business Model
- By Country
- Market Attractiveness Analysis
- By Country
- By Solution
- By Application
- By Indication
- By Business Model
- Key Takeaways
- Latin America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Brazil
- Chile
- Rest of Latin America
- By Solution
- By Application
- By Indication
- By Business Model
- By Country
- Market Attractiveness Analysis
- By Country
- By Solution
- By Application
- By Indication
- By Business Model
- Key Takeaways
- Western Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By Solution
- By Application
- By Indication
- By Business Model
- By Country
- Market Attractiveness Analysis
- By Country
- By Solution
- By Application
- By Indication
- By Business Model
- Key Takeaways
- Eastern Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By Solution
- By Application
- By Indication
- By Business Model
- By Country
- Market Attractiveness Analysis
- By Country
- By Solution
- By Application
- By Indication
- By Business Model
- Key Takeaways
- East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- China
- Japan
- South Korea
- By Solution
- By Application
- By Indication
- By Business Model
- By Country
- Market Attractiveness Analysis
- By Country
- By Solution
- By Application
- By Indication
- By Business Model
- Key Takeaways
- South Asia and Pacific Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By Solution
- By Application
- By Indication
- By Business Model
- By Country
- Market Attractiveness Analysis
- By Country
- By Solution
- By Application
- By Indication
- By Business Model
- Key Takeaways
- Middle East & Africa Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By Solution
- By Application
- By Indication
- By Business Model
- By Country
- Market Attractiveness Analysis
- By Country
- By Solution
- By Application
- By Indication
- By Business Model
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Canada
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Mexico
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Brazil
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Chile
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Germany
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- UK
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Italy
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Spain
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- France
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- India
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- China
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Japan
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- South Korea
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Russia
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Poland
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Hungary
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- South Africa
- Pricing Analysis
- Market Share Analysis, 2024
- By Solution
- By Application
- By Indication
- By Business Model
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Solution
- By Application
- By Indication
- By Business Model
- Competition Analysis
- Competition Deep Dive
- Teladoc Health, Inc.
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Click Therapeutics, Inc.
- Welldoc
- HYGIEIA
- DarioHealth Corp
- BigHealth
- Orexo AB
- Akili Interactive Labs, Inc.
- Freespira
- Voluntis
- Kaia Health
- Kaiku Health
- Theranica Bio-Electronics Ltd.
- Propeller Health
- Orexo US, Inc.
- TALi Digital Limited
- Limbix Health, Inc.
- Teladoc Health, Inc.
- Competition Deep Dive
- Assumptions & Acronyms Used
- Research Methodology
List of Tables
- Table 1: Global Market Value (USD Million) Forecast by Region, 2020-2035
- Table 2: Global Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 3: Global Market Value (USD Million) Forecast by Application, 2020-2035
- Table 4: Global Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 5: Global Market Value (USD Million) Forecast by Business Model, 2020-2035
- Table 6: North America Market Value (USD Million) Forecast by Country, 2020-2035
- Table 7: North America Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 8: North America Market Value (USD Million) Forecast by Application, 2020-2035
- Table 9: North America Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 10: North America Market Value (USD Million) Forecast by Business Model, 2020-2035
- Table 11: Latin America Market Value (USD Million) Forecast by Country, 2020-2035
- Table 12: Latin America Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 13: Latin America Market Value (USD Million) Forecast by Application, 2020-2035
- Table 14: Latin America Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 15: Latin America Market Value (USD Million) Forecast by Business Model, 2020-2035
- Table 16: Western Europe Market Value (USD Million) Forecast by Country, 2020-2035
- Table 17: Western Europe Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 18: Western Europe Market Value (USD Million) Forecast by Application, 2020-2035
- Table 19: Western Europe Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 20: Western Europe Market Value (USD Million) Forecast by Business Model, 2020-2035
- Table 21: Eastern Europe Market Value (USD Million) Forecast by Country, 2020-2035
- Table 22: Eastern Europe Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 23: Eastern Europe Market Value (USD Million) Forecast by Application, 2020-2035
- Table 24: Eastern Europe Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 25: Eastern Europe Market Value (USD Million) Forecast by Business Model, 2020-2035
- Table 26: East Asia Market Value (USD Million) Forecast by Country, 2020-2035
- Table 27: East Asia Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 28: East Asia Market Value (USD Million) Forecast by Application, 2020-2035
- Table 29: East Asia Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 30: East Asia Market Value (USD Million) Forecast by Business Model, 2020-2035
- Table 31: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2020-2035
- Table 32: South Asia and Pacific Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 33: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2020-2035
- Table 34: South Asia and Pacific Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 35: South Asia and Pacific Market Value (USD Million) Forecast by Business Model, 2020-2035
- Table 36: Middle East & Africa Market Value (USD Million) Forecast by Country, 2020-2035
- Table 37: Middle East & Africa Market Value (USD Million) Forecast by Solution , 2020-2035
- Table 38: Middle East & Africa Market Value (USD Million) Forecast by Application, 2020-2035
- Table 39: Middle East & Africa Market Value (USD Million) Forecast by Indication, 2020-2035
- Table 40: Middle East & Africa Market Value (USD Million) Forecast by Business Model, 2020-2035
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2020-2035
- Figure 3: Global Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
- Figure 4: Global Market Y-o-Y Growth Comparison by Region, 2025-2035
- Figure 5: Global Market Attractiveness Analysis by Region
- Figure 6: North America Market Incremental Dollar Opportunity, 2025-2035
- Figure 7: Latin America Market Incremental Dollar Opportunity, 2025-2035
- Figure 8: Western Europe Market Incremental Dollar Opportunity, 2025-2035
- Figure 9: Eastern Europe Market Incremental Dollar Opportunity, 2025-2035
- Figure 10: East Asia Market Incremental Dollar Opportunity, 2025-2035
- Figure 11: South Asia and Pacific Market Incremental Dollar Opportunity, 2025-2035
- Figure 12: Middle East & Africa Market Incremental Dollar Opportunity, 2025-2035
- Figure 13: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 14: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 15: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 16: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 17: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 18: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 19: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 20: Global Market - Tier Structure Analysis
- Figure 21: Global Market - Company Share Analysis
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
